Cullinan Oncology LLC (CGEM) Insider Trading

Total insider buys:
  • $11,332,672.00
Total insider sells:
  • $12,571,120.72
Most recent insider trade:
  • Aug. 4, 2022
Most active insider trader:
  • Oncology Impact Fund L.P. Ubs
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 4, 2022Major Shareholder25,989$14.31Sell$371,902.59
Aug. 2, 2022Major Shareholder4,792$14.10Sell$67,567.20
July 25, 2022Insider8,000$14.51Sell$116,080.00
July 18, 2022Insider5,042$15.06Sell$75,932.52
July 11, 2022Acting Chief Business Officer39,800$13.33Sell$530,534.00
June 23, 2022Major Shareholder29,631$13.00Sell$385,203.00
June 21, 2022Major Shareholder22,319$12.77Sell$285,013.63
June 6, 2022CEO8,090$12.40Buy$100,316.00
June 1, 2022Major Shareholder751,396$11.00Buy$8,265,356.00
May 16, 2022Major Shareholder35,158$11.23Sell$394,824.34
May 12, 2022Major Shareholder264,072$9.25Sell$2,442,666.00
April 1, 2022Major Shareholder276,000$10.75Buy$2,967,000.00
Oct. 18, 2021Insider4,000$21.42Sell$85,680.00
Oct. 15, 2021CFO8,000$25.00Sell$200,000.00
Oct. 15, 2021Insider19,574$25.00Sell$489,350.00
Oct. 7, 2021Insider1,079$25.00Sell$26,975.00
Sept. 20, 2021Insider4,000$24.51Sell$98,040.00
Sept. 15, 2021Major Shareholder6,425$29.16Sell$187,353.00
Sept. 15, 2021Director888$29.16Sell$25,894.08
Sept. 13, 2021Major Shareholder3,595$29.10Sell$104,614.50
Sept. 13, 2021Director497$29.10Sell$14,462.70
Sept. 9, 2021Major Shareholder13,727$29.35Sell$402,887.45
Sept. 9, 2021Director1,898$29.35Sell$55,706.30
Sept. 7, 2021Director3,465$29.04Sell$100,623.60
Sept. 7, 2021Insider28,118$28.95Sell$814,016.10
Sept. 7, 2021Major Shareholder25,067$29.04Sell$727,945.68
Sept. 3, 2021Major Shareholder12,731$29.60Sell$376,837.60
Sept. 3, 2021Director1,760$29.60Sell$52,096.00
Sept. 1, 2021Director790$29.47Sell$23,281.30
Sept. 1, 2021Major Shareholder5,714$29.47Sell$168,391.58
Aug. 30, 2021Director4,285$29.30Sell$125,550.50
Aug. 30, 2021Major Shareholder31,001$29.30Sell$908,329.30
Aug. 27, 2021Major Shareholder13,357$29.09Sell$388,555.13
Aug. 27, 2021Director1,846$29.09Sell$53,700.14
Aug. 25, 2021Major Shareholder1,713$29.09Sell$49,831.17
Aug. 25, 2021Director237$29.09Sell$6,894.33
Aug. 23, 2021Director7,376$29.11Sell$214,715.36
Aug. 23, 2021Major Shareholder53,359$29.11Sell$1,553,280.49
Aug. 11, 2021Director347$29.05Sell$10,080.35
Aug. 11, 2021Major Shareholder2,510$29.05Sell$72,915.50
Aug. 9, 2021Insider21,204$26.57Sell$563,390.28
First«1 of 1»Last
  • Insiders are both buying and selling Cullinan Oncology LLC stock.

  • The insider traders at Cullinan Oncology LLC are: Oncology Impact Fund L.P. Ubs, Ansbert Gadicke, Vision Scs F2, Leigh Zawel, Jennifer Michaelson, Bvf Partners L P/Il, Bioscience I 2017 Ltd F2, Corrine Savill, Nadim Ahmed, Jeffrey Trigilio, and Savill Corrine

  • The most active insider trader at Cullinan Oncology LLC is Oncology Impact Fund L.P. Ubs with 11 trades.

  • Oncology Impact Fund L.P. Ubs has sold the most Cullinan Oncology LLC stock with a total value of $5,128,294.40.

  • Bvf Partners L P/Il has bought the most Cullinan Oncology LLC stock with a total value of $19,497,712.00.

  • The most recent insider trade for Cullinan Oncology LLC was on Aug. 4, 2022.

  • The single biggest insider buy for Cullinan Oncology LLC was from Bvf Partners L P/Il with a total value of $8,265,356.00 on June 1, 2022.

  • The single biggest insider sell for Cullinan Oncology LLC was from Vision Scs F2 with a total value of $2,442,666.00 on May 12, 2022.